Abstract:The establishment of human embryonic stem cell (hESC) lines has generated a great deal of excitement in the fields of stem cell biology and regenerative medicine. It has been hoped that hESCs and somatic stem cells could be potential sources of cells to regenerate or rejuvenate damaged tissues. Yet studies on the biology of hESCs have been hindered by difficulties in manipulating this type of cells in culture in vitro. This is largely due to lack of full understanding of the molecular and cellular basis for maintenance of hESC pluripotency. Since mESCs have received extensive attentions in the past two decades and relatively more information is available, characterization of hESCs has been naturally conducted by referencing mESC properties. Recent studies from a number of laboratories have suggested distinct biological properties and molecular signaling mechanisms between human and mouse embryonic stem cells (hESCs and mESCs). Here we report that Shp2, an intracellular tyrosine phosphatase with two SH2 domains, has a conserved role in promoting signals resulting in differentiation of both hESCs and mESCs. Homozygous ablation of Shp2 in mESCs resulted in impaired differentiation into all three germ layer cell lineages accompanied by improved self-renewal. siRNA-mediated Shp2 knockdown in hESCs resulted in a very similar phenotype of impaired differentiation. Furthermore, small molecule inhibitors for Shp2 enzyme suppressed both hESC and mESC differentiation in vitro. Shp2 modulates LIF and BMP signals flowing through Erk, Stat3 and Smad pathways in mESCs and also regulates FGF and BMP signaling through the Erk and Smad pathways in hESCs. These results reveal a common signaling mechanism shared by hESCs and mESCs via Shp2 modulation of overlapping and distinct pathways. Pharmaceutical intervention of Shp2 activity might be a practical means for amplification of hESCs in vitro.

Loss of 18q alters TGFβ signalling affecting anteroposterior neuroectodermal fate in human embryonic stem cells

TET1 Deficiency Impairs Morphogen-free Differentiation of Human Embryonic Stem Cells to Neuroectoderm

TP53 Promotes Lineage Commitment of Human Embryonic Stem Cells Through Ciliogenesis and Sonic Hedgehog Signaling

The spontaneous differentiation and chromosome loss in iPSCs of human trisomy 18 syndrome

Trisomy 12 compromises the mesendodermal differentiation propensity of human pluripotent stem cells

Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality.

Germline Competency of Human Embryonic Stem Cells Depends on Eomesodermin †

CHD8 Safeguards Early Neuroectoderm Differentiation in Human ESCs and Protects from Apoptosis During Neurogenesis

A Conserved Role of Shp2 in Regulation of Human and Mouse Es Cell Differentiation

Defective insulin receptor signaling in hPSCs skews pluripotency and negatively perturbs neural differentiation

Individual variation in the emergence of anterior-to-posterior neural fates from human pluripotent stem cells

Loss of Polycomb Group Protein Pcgf1 Severely Compromises Proper Differentiation of Embryonic Stem Cells

Identification and Characterisation of the Early Differentiating Cells in Neural Differentiation of Human Embryonic Stem Cells

Modeling Abnormal Early Development with Induced Pluripotent Stem Cells from Aneuploid Syndromes

Neuronal Defects in a Human Cellular Model of 22q11.2 Deletion Syndrome.

Altered development and network connectivity in a human neuronal model of 15q11.2 deletion-related neurodevelopmental disorders

Gains of 12p13.31 delay WNT-mediated initiation of hPSC differentiation and promote residual pluripotency in a cell cycle dependent manner

TGFβ Signaling Hyperactivation-Induced Tumorigenicity During the Derivation of Neural Progenitors from Mouse ESCs

Aneuploid embryonic stem cells exhibit impaired differentiation and increased neoplastic potential

Loss of Pten Causes Tumor Initiation Following Differentiation of Murine Pluripotent Stem Cells Due to Failed Repression of Nanog.

E2A Regulates Neural Ectoderm Fate Specification in Human Embryonic Stem Cells.